We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
The UK Health Security Agency (UKHSA) has detected a single confirmed human case of Clade Ib mpox.
The latest weekly flu surveillance data published by UKHSA today shows flu case numbers are twice as high among school children, aged 5 to 14 years.
Letter from Health Minister Andrew Gwynne MP confirming the UK Health Security Agency’s role and priorities for the financial year 2024 to 2025.
The UK has announced a package of measures to tackle the outbreaks of mpox and Marburg in central Africa
Scientists at VDEC use ‘organ-on-a-chip’ models to study infections and immune responses, aiming to improve vaccine testing and reduce reliance on animal research.
Latest data from the UK Health Security Agency (UKHSA) also highlights that testing remains lower than before the COVID-19 pandemic.
UKHSA with DHSC and NHS launch Get Winter Strong campaign to remind those at risk to get their vaccinations to fight off the onslaught of winter viruses.
UKHSA is advising students to use condoms when having sex with new or casual partners.
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
Additional vaccines will help ensure the UK can protect those that may be at higher risk of coming into contact with mpox.
The measles vaccination is part of the NHS Routine Childhood Immunisation Programme – with 1 dose offered at 1 year and a second dose at 3 years 4 months.
The UK Health Security Agency is encouraging students to make the healthiest start to their studies possible.
The UK Health Security Agency responds to the World Health Organisation declaring an mpox outbreak a public health emergency of international concern.
Between June 2022 and May 2024, 15 ceftriaxone-resistant gonorrhoea cases were detected in England
Study shows new RSV vaccine for pregnant women could prevent 5,000 hospitalisations and 15,000 emergency department attendances for infants.
UKHSA urges pregnant women to get vaccinated to protect their newborn babies as whooping cough cases rise to over 10,000
JCVI advises government on the COVID-19 vaccination programme for autumn 2024
Antimicrobial resistance to Group B Streptococcus (GBS) antibiotics is growing. This puts newborns at risk. VDEC is supporting a new vaccine to cut antibiotic use
VDEC developed a standardised assay to reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).